Home - Products - Others - Other Targets - (Tyr34)-pTH (7-34) amide (bovine)

(Tyr34)-pTH (7-34) amide (bovine)

CAS No. 86292-93-5

(Tyr34)-pTH (7-34) amide (bovine)( ——— )

Catalog No. M40376 CAS No. 86292-93-5

(TYR34)-PTH (7-34) AMIDE (BOVINE) is a peptide derivative of Parathyroid Hormone (PTH).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (Tyr34)-pTH (7-34) amide (bovine)
  • Note
    Research use only, not for human use.
  • Brief Description
    (TYR34)-PTH (7-34) AMIDE (BOVINE) is a peptide derivative of Parathyroid Hormone (PTH).
  • Description
    (TYR34)-PTH (7-34) AMIDE (BOVINE) is a peptide derivative of Parathyroid Hormone (PTH).
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    86292-93-5
  • Formula Weight
    3496.08
  • Molecular Formula
    C156H244N48O40S2
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. R L Shew, Inhibitory effect of Tyr34bPTH-(7-34)-amide on bPTH-(1-34) ability to reduce uterine contraction. Pharmacology. 1989;39(6):390-6.?
molnova catalog
related products
  • Feeblin

    Feeblin(IRF5-IN-1) is a protein degradation inducer that specifically blocks pro-inflammatory signaling pathways associated with autoimmune diseases and can be used to study immune system disorders in the class of systemic lupus erythematosus.

  • 11-(Methylsulfinyl)u...

    11-(Methylsulfinyl)undecylglucosinolate

  • Soyasapogenol A

    Soyasapogenol A shows estrogenic and hepatoprotective activities, it directly prevents apoptosis of hepatocytes, and secondly, inhibits the elevation of plasma TNF-α±, which consequently resulted in the prevention of liver damage in the concanavalin A-induced hepatitis model.